Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 27:75:102745.
doi: 10.1016/j.eclinm.2024.102745. eCollection 2024 Sep.

Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial

Affiliations

Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial

Salome Charalambous et al. EClinicalMedicine. .

Abstract

Background: Poor treatment adherence contributes to lower treatment completion and higher loss to follow-up among people with tuberculosis (PWTB). Medication monitors have shown some evidence of improved adherence.

Methods: We conducted a cluster randomised trial in 18 primary health clinics in South Africa between May 2019-February 2022. Persons (aged ≥ 2 years) with drug-sensitive tuberculosis (DS-TB) were enrolled. All participants were provided with monitors which were silent in the standard of care (SoC) arm. In the intevention arm, weekly adherence reports were reviewed and participants received intensified support as appropriate (text, phone call, home visit, motivational counselling). The primary outcome was adherence, which was calculated as days box was opened (proxy for drug taken)/total expected treatment days as a binary variable (<80% versus ≥80%). Analysis took into account clustered design. The trial was registered with the Pan African Trial Registry PACTR20190268115772.

Findings: We enrolled 2727 participants (38% women, median age 36 (IQR 27-45 years), of whom 2584 had available adherence data. The primary outcome (measured as ≥80% adherence) was higher in intervention versus SoC arm (81.0% versus 50.8%, adjusted risk ratio (ARR) 1.51 (1.36-1.66). Similarly, overall percentage adherence was higher in intervention versus SoC arm (88.5% versus 69.7%, adjusted risk difference 16.8% (13.3%-20.4%)).

Interpretation: People with DS-TB had improved treatment adherence in the intervention arm. We believe the effect on adherence is important and warrants continued use and evaluation of these technologies.

Funding: The study is funded by Bill & Melinda Gates Foundation, Uinted States, the Stop TB Partnership, Switzerland, and the South African Medical Research Council, South Africa.

Keywords: Adherence; Differentiated care approach; Medication monitors; Recurrence; Treatment outcomes; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

CO received honoraria from MSD in Dec 2022 and November 2023 for consultation at their Africa ART meetings. PN has received support from BMGF to attend the Union Conference on Lung Health and SA TB Conference. All other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Consort diagram for adherence population. n = number; MDR = multi-drug resistance; TB = tuberculosis; d = days.
Fig. 2
Fig. 2
Forest plot for subgroup analysis for primary adherence outcome (unadjusted). SoC = Standard of Care; Int = Intervention; CI = confidence interval; HIV = human immunodeficiency virus; gr = grade; ART = antiretroviral; Bact = bacteriological; CI = confidence interval; GP = Gauteng province; KZN = Kwazulu Natal province; WC = Western Cape province. The box represents the risk ratio; and the horizontal line through the box is the 95% confidence interval.

References

    1. World Health Organisation . World Health Organisation; Geneva: 2023. Global TB report.
    1. Vijay S., Kumar P., Chauhan L.S., Vollepore B.H., Kizhakkethil U.P., Rao S.G. Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PLoS One. 2010;5 - PMC - PubMed
    1. Chimeh R.A., Gafar F., Pradipta I.S., et al. Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review. Int J Tuberculosis Lung Dis. 2020;24:811–819. - PubMed
    1. Thomas A., Gopi P.G., Santha T., et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tubercul Lung Dis. 2005;9:556–561. - PubMed
    1. Imperial M.Z., Nahid P., Phillips P.P.J., et al. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nat Med. 2018;24:1708–1715. - PMC - PubMed

LinkOut - more resources